These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14609776)

  • 1. The importance of screening for hemochromatosis.
    Dubois S; Kowdley KV
    Arch Intern Med; 2003 Nov; 163(20):2424-6; author reply 2426. PubMed ID: 14609776
    [No Abstract]   [Full Text] [Related]  

  • 2. Hereditary hemochromatosis and its elusive natural history.
    McDonnell SM; Parrish RG
    Arch Intern Med; 2003 Nov; 163(20):2421-3; author reply 2427. PubMed ID: 14609775
    [No Abstract]   [Full Text] [Related]  

  • 3. HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload.
    Remacha AF; Carrasco M; Sardá MP; Barceló MJ; Baiget M
    Haematologica; 1999 Mar; 84(3):284-5. PubMed ID: 10189401
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiology and diagnostic testing for hemochromatosis and iron overload.
    Adams PC
    Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of hereditary hemochromatosis and biochemical iron overload in primary care: a multicenter case finding study in Spain.
    Freixenet N; Moreno-Rosel MS; Barceló MJ; Serrano A; Payà M; Crespo L; Pérez-Lucena MJ; Altés A; Baiget M; Félez J
    Am J Hematol; 2010 Apr; 85(4):294-6. PubMed ID: 20196172
    [No Abstract]   [Full Text] [Related]  

  • 6. HFE hemochromatosis: influence of dietary iron intake on the iron overload of C282Y homozygous patients.
    Saliou P; Le Gac G; Mérour MC; Tripogney C; Chanu B; Gourlaouen I; Nousbaum JB; Férec C; Scotet V
    Ann Hematol; 2015 Jul; 94(7):1225-7. PubMed ID: 25740382
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for iron overload and HFE mutations in a university hospital.
    Remacha AF; Carrasco M; Sardà MP; Barceló MJ; Blesa I; Baiget M
    Haematologica; 2000 Aug; 85(8):873-4. PubMed ID: 10942939
    [No Abstract]   [Full Text] [Related]  

  • 8. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for hemochromatosis and iron overload: satisfaction with results notification and understanding of mailed results in unaffected participants of the HEIRS study.
    Harrison HF; Harrison BW; Walker AP; Lohman K; Ellis SD; Hall MA; Reiss J; Adams PC; Holup J; Acton RT; Bent T; Rivers C; Fadojutimi-Akinsiku M
    Genet Test; 2008 Dec; 12(4):491-500. PubMed ID: 18939938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of iron overload syndrome].
    Polunina TE; Maev IV
    Eksp Klin Gastroenterol; 2010; (5):61-8. PubMed ID: 20731136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for hemochromatosis in a population with abnormal iron status.
    Veneri D; Krampera M; Zaffanello L; de Matteis G; Solero P; Franchini M
    Haematologica; 2003 May; 88(5):593-4. PubMed ID: 12745279
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation.
    Distante S
    Scand J Clin Lab Invest; 2006; 66(2):83-100. PubMed ID: 16537242
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical guidelines: HFE hemochromatosis-screening, diagnosis and management.
    Barton JC; Adams PC
    Nat Rev Gastroenterol Hepatol; 2010 Sep; 7(9):482-4. PubMed ID: 20811364
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemochromatosis case definition: out of focus?
    Adams PC
    Nat Clin Pract Gastroenterol Hepatol; 2006 Apr; 3(4):178-9. PubMed ID: 16582939
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixture models of serum iron measures in population screening for hemochromatosis and iron overload.
    McLaren CE; Li KT; McLaren GD; Gordeuk VR; Snively BM; Reboussin DM; Barton JC; Acton RT; Dawkins FW; Harris EL; Eckfeldt JH; Moses GC; Adams PC
    Transl Res; 2006 Oct; 148(4):196-206. PubMed ID: 17002922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter by Sullivan regarding article, "HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: the hemochromatosis and iron overload screening study".
    Sullivan JL
    Circ Cardiovasc Genet; 2009 Jun; 2(3):e1. PubMed ID: 20031587
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of HFE mutations in patients with iron overload.
    Bittencourt PL
    Sao Paulo Med J; 2007 Jan; 125(1):65-7. PubMed ID: 17505690
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hereditary hemochromatosis--a common genetic disease].
    Stål P; Hultcrantz R
    Lakartidningen; 2012 Nov 14-20; 109(46):2097-9. PubMed ID: 23259216
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.